{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:21:09Z","timestamp":1758190869020,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:00:00Z","timestamp":1610755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ihj.2021.01.017","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T21:26:27Z","timestamp":1610832387000},"page":"249-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors in aortic stenosis - Is this the light at the end of the tunnel for patients with aortic stenosis?"],"prefix":"10.1016","volume":"73","author":[{"given":"Sourabh","family":"Agstam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1607-4077","authenticated-orcid":false,"given":"Anunay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ihj.2021.01.017_bib1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.ihj.2021.01.017_bib2","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","article-title":"The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis","volume":"63","author":"Coffey","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ihj.2021.01.017_bib3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ihj.2020.06.013","article-title":"Etiology and distribution of isolated aortic stenosis in Indian patients - a study from a large tertiary care hospital in north India","volume":"72","author":"Sahu","year":"2020","journal-title":"Indian Heart J"},{"issue":"3","key":"10.1016\/j.ihj.2021.01.017_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ihj.2014.03.010","article-title":"Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience","volume":"66","author":"Manjunath","year":"2014","journal-title":"Indian Heart J"},{"key":"10.1016\/j.ihj.2021.01.017_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.6","article-title":"Calcific aortic stenosis","volume":"2","author":"Lindman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.ihj.2021.01.017_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jacc.2013.05.105","article-title":"Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization","volume":"63","author":"Mahmut","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2021.01.017_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcmg.2014.09.016","article-title":"Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study","volume":"8","author":"Capoulade","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ihj.2021.01.017_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCULATIONAHA.115.018139","article-title":"A\u00a0not-so-little role for lipoprotein(a) in the development of calcific aortic valve disease","volume":"132","author":"Rogers","year":"2015","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ihj.2021.01.017_bib8","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"O\u2019Brien","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ihj.2021.01.017_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jacc.2007.12.031","article-title":"Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis","volume":"51","author":"Bosse","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2021.01.017_bib10","article-title":"Clinical and genetic risk factors for calcific valve disease","volume":"vol. 53","author":"Owens","year":"2013"},{"key":"10.1016\/j.ihj.2021.01.017_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ihj.2021.01.017_bib12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A\u00a0new serum type system in man-the LP system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"3","key":"10.1016\/j.ihj.2021.01.017_bib13","first-page":"99-106","article-title":"Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)","volume":"5","author":"Pedersen","year":"1998","journal-title":"Atherosclerosis Suppl"},{"issue":"11","key":"10.1016\/j.ihj.2021.01.017_bib14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jacc.2015.07.045","article-title":"How does elevated lipoprotein(a) cause aortic valve stenosis?","volume":"66","author":"Nordestgaard","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.ihj.2021.01.017_bib15","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2016-1206","article-title":"PCSK9 R46L loss-of-function mutation reduces lipoprotein(a), LDL cholesterol, and risk of aortic valve stenosis","volume":"101","author":"Langsted","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ihj.2021.01.017_bib16","article-title":"Involvement of proprotein convertase subtilisin\/kexin type 9 (PCSK9) in aortic valvular calcification","volume":"39","author":"Poggio","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2021.01.017_bib17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2018.08.020","article-title":"Novel pharmacological targets for calcific aortic valve disease: prevention and treatments","volume":"136","author":"Myasoedova","year":"2018","journal-title":"Pharmacol Res"},{"issue":"5","key":"10.1016\/j.ihj.2021.01.017_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jacc.2006.07.072","article-title":"Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis","volume":"49","author":"Moura","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ihj.2021.01.017_bib19","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"Scottish aortic stenosis and lipid lowering trial, impact on regression (SALTIRE) investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1016\/j.ihj.2021.01.017_bib20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ihj.2021.01.017_bib21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.ihj.2021.01.017_bib22","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ihj.2021.01.017_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An exploratory analysis of proprotein convertase subtilisin\/kexin type 9 inhibition and aortic stenosis in the FOURIER trial","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"22","key":"10.1016\/j.ihj.2021.01.017_bib24","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCULATIONAHA.116.023997","article-title":"Medical treatment of aortic stenosis","volume":"134","author":"Marquis","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ihj.2021.01.017_bib25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjcard.2009.02.051","article-title":"Osteoporosis treatment and progression of aortic stenosis","volume":"104","author":"Skolnick","year":"2009","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.ihj.2021.01.017_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/nu10040386","article-title":"Bicuspid aortic valve stenosis and the effect of vitamin K2 on calcification using 18F-sodium fluoride positron emission tomography\/magnetic resonance: the BASIK2 rationale and trial design","volume":"10","author":"Peeters","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.ihj.2021.01.017_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jcmg.2018.12.005","article-title":"Precision medicine for aortic stenosis: The future of cardiology today","volume":"12","author":"Chandrashekhar","year":"2019","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483221000171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483221000171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:54:20Z","timestamp":1758081260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483221000171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0019483221000171"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2021.01.017","relation":{},"ISSN":["0019-4832"],"issn-type":[{"type":"print","value":"0019-4832"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) inhibitors in aortic stenosis - Is this the light at the end of the tunnel for patients with aortic stenosis?","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2021.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Cardiological Society of India. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}